Health

Humacyte Expands Commercial and Business Development Opportunities Through Realignment of Ex-U.S. Rights to Symvess

April 24, 2026 08:00 ET  | Source: Humacyte, Inc - Ex-U.S. rights realigned under amendment to distribution agreement with Fresenius…

17 hours ago

Oncotelic Therapeutics Provides Corporate Update on Partnership Strategy

AGOURA HILLS, Calif., April 24, 2026 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (“Oncotelic” or the “Company”), a clinical-stage biopharmaceutical company…

17 hours ago

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

April 24, 2026 08:00 ET  | Source: Aligos Therapeutics SOUTH SAN FRANCISCO, Calif., April 24, 2026 (GLOBE NEWSWIRE) -- Aligos…

17 hours ago

First-quarter 2026 revenue

Revenue as at 31 March 2026 stood at €1,336m, up +4.9% on an organic basis compared with the first quarter…

2 days ago

IMAAVY (nipocalimab)shows over two years of sustained disease control in a broad population with generalised myasthenia gravis (gMG)

Through 120 weeks of follow-up, nipocalimab delivered sustained clinical improvements and reductions in total IgG in antibody-positive adult patients including…

2 days ago

Catheter Precision to Attend and Share New Clinical Data at the 47th Annual Heart Rhythm Society Meeting

April 23, 2026 12:00 ET  | Source: Catheter Precision, Inc. VIVO System to be featured in educational sessions at HRS…

2 days ago

SkinHealth Systems Inc. Appoints Three New Independent Directors to Board

Kenneth Tripp, Dr. Sachin Shridharani, and E. Scott Beattie bring deep expertise in medical devices, aesthetic medicine, and global consumer…

2 days ago

TOMI Environmental Solutions Scales Automation with SteraMist iHP Robot Upgrade; Targets Fast Growing Robotaxi Market

Pairing Decontamination Versatility with Domestic Lithium Power to Meet the Global Demand for High-Performance Automated Disinfection April 22, 2026 16:05…

2 days ago

Abivax to Present Data on Obefazimod at Digestive Disease Week

Abivax to Present Data on Obefazimod at Digestive Disease Week® Presentations Highlight Comprehensive Efficacy, Safety, and Patient-Reported Outcomes from the…

2 days ago

Kyverna Presents Registrational Trial Primary Analysis for Miv-cel in Stiff Person Syndrome Demonstrating Statistically Significant, Durable Clinical Benefit Across All Endpoints in an Oral, Late-Breaker Session at AAN Annual Meeting

Single-dose of miv-cel achieved robust and durable improvements in mobility, reversed disability scores, and eliminated the need for chronic immunotherapies…

3 days ago